Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Vectura Group Fundamentals

Company Name Vectura Last Updated 06 Apr 2020
Industry Health Care Sector Pharmaceuticals
Shares in Issue (m) 604.28 Market Cap (£m) 543.85
PE Ratio -26.47 Div per Share () 0.00
Div Yield 0.00 Div Cover 0.00
EPS -3.40 EPS Growth (%) 74.24
PEG -0.36 DPS Growth (%) n/a
Debt Ratio 10.12 Debt Equity Ratio 0.42
Net Gearing 7.01 Gross Gearing 20.97
Asset Equity Ratio 1.27 Cash Equity Ratio 17.67
Quick Ratio 1.85 Current Ratio 2.28
Price To Book Value 1.30 ROCE -5.59

Vectura Group Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total
Special Dividend 10 Oct 2019 25 Oct 2019 GBX 6.00

Vectura Group Company Financials

Assets (£m) 2019 2018 2017
Tangible Assets 55 58 53
Intangible Assets 326 383 497
Investments 3 10 7
Total Fixed Assets 385 451 557
Stocks 28 27 23
Debtors 44 35 34
Cash & Equivalents 74 108 104
Other Assets 0 0 0
Total Assets 531 621 719
Liabilities (£m) 2019 2018 2017
Creditors within 1 year 64 72 70
Creditors after 1 year 47 55 70
Other Liabilities 0 0 0
Total Liabilities 111 127 140
Net assets 419 494 579
Equity (£m) 2019 2018 2017
Called up share capital 0 0 0
Share Premium 62 62 103
Profit / Loss -26 -105 -102
Other Equity 350 487 584
Preference & Minorities 0 0 0
Total Capital Employed 419 494 579
Ratios 2019 2018 2017
Debt Ratio 10.12 9.98 10.78
Debt-to-Equity 0.42 0.43 0.50
Net Gearing 7.01 3.04 5.05
Gross Gearing 20.97 20.45 19.49
Assets / Equity 1.27 1.26 1.24
Cash / Equity 17.67 21.89 17.93
EPS -3.40 -13.20 -12.60
Cash Flow (£m) 2019 2018 2017
Cash from operating activities 20 30 26
Cashflow before financing 14 18 17
Increase in Cash -34 5 11
Income (£m) 2019 2018 2017
Turnover 178 161 148
Cost of sales 83 62 57
Gross Profit 95 99 91
Operating Profit -27 -105 -96
Pre-Tax profit -26 -105 -102
Profit / Loss for the year 0 0 0

Vectura Group Company Background

Sector Pharmaceuticals
Activities Vectura Group plc is an industry-leading inhaled product formulation, device design and development business offering a uniquely integrated inhaled drug delivery platform. It develops inhalation products to help patients suffering from airways diseases. Vectura has ten key inhaled and eleven non-inhaled products marketed by partners with global royalty streams, and a diverse partnered portfolio of drugs in clinical development. Our partners include Hikma, Novartis, Sandoz, Mundipharma, Kyorin, Baxter, GSK, UCB, Bayer, Chiesi, Almirall, Dynavax and Tianjin KingYork. Vectura's strategy is to fully leverage its differentiated technology and skills, maximising value by enhancing the delivery and performance of inhaled products, and through the development of high-quality generic alternatives to branded therapies.
Latest Interim Date 10 Sep 2019
Latest Fiscal Year End Date 17 Mar 2020

Vectura Group Directors

Appointed Director Position
07 Nov 2019 William Downie Chief Executive Officer
22 Oct 2018 Paul Andrew Fry Chief Financial Officer
01 Dec 2013 Bruno Francois Jules Angelici Non-Executive Chairman
01 Apr 2015 Dr Per-Olof Andersson Non-Executive Director
29 Mar 2019 Dr Kevin Roger Kenneth Matthews Non-Executive Director
01 Dec 2017 Juliet Thompson Non-Executive Director
01 Feb 2011 Neil William Warner Non-Executive Director
10 Jun 2016 Dr Thomas Werner Non-Executive Director
01 Jun 2018 Anne Clem Whitaker Non-Executive Director

Vectura Group Contact Details

Company Name Vectura
Company Address 1 Prospect West, Chippenham, Wiltshire SN14 6FH.
Company Telephone +44 (0)1249 667700
Company Website http://www.vectura.com/

Vectura Group Advisors

Auditor Name Deloitte & Touche LLP
Auditor Address City House, 126-130 Hills Road , Cambridge CB2 1RY.
Auditor Website http://www.deloitte.com/
Auditor Telephone +44 (0)1223 460 222
Registrar Name Computershare Investor Service
Registrar Address The Pavillions, Bridgwater Road, Bristol BS99 1XZ.
Registrar Website http://www-uk.computershare.com/
Registrar Telephone 0870 702 0010
Broker Name Peel Hunt
Broker Address Moor House, 120 London Wall, London EC2Y 5ET.
Broker Website http://www.peelhunt.com/
Broker Telephone +44 (0)20 7418 8900
Adviser Name Peel Hunt
Adviser Address Moor House, 120 London Wall, London EC2Y 5ET.
Adviser Website http://www.peelhunt.com/
Adviser Telephone +44 (0)20 7418 8900
Solicitor Name Olswang
Solicitor Address 90 High Holborn, London WC1V 6XX.
Solicitor Website http://www.olswang.com/
Solicitor Telephone +44 (0) 20 7067 3000
Stockbroker Name JPMorgan Cazenove
Stockbroker Address 20 Moorgate, London EC2R 6DA.
Stockbroker Website http://www.jpmorgancazenove.com/
Stockbroker Telephone +44 (0)20 7588 2828